Keratoconus in Children in Tunisia: Epidemiological, Clinical and Therapeutic Features

Overview

Journal Tunis Med

Date 2025 Jan 15

PMID 39812204

Authors

Sonda Kammoun

Kmar Maaloul

Mona Rekik

Karim Chaabouni

Amira Trigui

Affiliations

Soon will be listed here.

Abstract

Aim: To report the clinical and therapeutic particularities of pediatric keratoconus (KC).

Methods: Retrospective study focusing on patients aged less than 18 years, presenting with KC and followed in a tertiary reference center in Sfax, Tunisia.

Results: Our study involved 38 eyes of 20 children. We found a mean age of 12.8 years, a family history of keratoconus for 25% of cases and an atopic background in 30% of children. The mean best-corrected visual acuity was 5.3/10, the mean myopia was -6.3D and the mean total astigmatism was -4.9D. The average maximum simulated keratometry (Kmax) was 54.6 D. The visual acuity decrease was correlated with the presence of corneal opacities, with all keratometric indices except Skewed Radial Axes (SRAX) at 3 and 5 mm, with all elevation parameters and those of pachymetry except the delocalization of the thinnest point. 71.1% of eyes were classified as clinical KC and 47% of eyes were classified as Amlser-Krumeich stage 4. 42.1% of eyes were fitted with glasses and 57.9% with contact lenses. Six patients (10 eyes) underwent cross-linking (CXL). We noted an evolution of the KC for 64.29% of eyes not treated with CXL and a stabilization of 80% of eyes treated with CXL. The difference in follow-up parameters between the two groups was significant.

Conclusion: Pediatric KC is a severe disease, often diagnosed at a late stage. CXL is a safe and effective way to stop the disease.

References

Naderan M, Rajabi M, Zarrinbakhsh P, Farjadnia M . Is keratoconus more severe in pediatric population?. Int Ophthalmol. 2016; 37(5):1169-1173. DOI: 10.1007/s10792-016-0382-5. View

Ertan A, Muftuoglu O . Keratoconus clinical findings according to different age and gender groups. Cornea. 2008; 27(10):1109-13. DOI: 10.1097/ICO.0b013e31817f815a. View

Leoni-Mesplie S, Mortemousque B, Mesplie N, Touboul D, Praud D, Malet F . [Epidemiological aspects of keratoconus in children]. J Fr Ophtalmol. 2012; 35(10):776-85. DOI: 10.1016/j.jfo.2011.12.012. View

Saleh S, Koo E, Lambert S, Manche E . Outcomes After Corneal Crosslinking for Keratoconus in Children and Young Adults. Cornea. 2021; 41(4):408-416. PMC: 10659218. DOI: 10.1097/ICO.0000000000002730. View

Marty A, Jurkiewicz T, Febvay C, Mouchel R, Burillon C . [Safety and efficiency of epithelium-off accelerated corneal cross-linking for progressive keratoconus in pediatric patients]. J Fr Ophtalmol. 2021; 44(6):828-834. DOI: 10.1016/j.jfo.2020.11.012. View

Polido J, Dos Xavier Santos Araujo M, Alexander J, Cabral T, Ambrosio Jr R, Freitas D . Pediatric Crosslinking: Current Protocols and Approach. Ophthalmol Ther. 2022; 11(3):983-999. PMC: 9114245. DOI: 10.1007/s40123-022-00508-9. View

El-Khoury S, Abdelmassih Y, Hamade A, Slim E, Cherfan C, Chelala E . Pediatric Keratoconus in a Tertiary Referral Center: Incidence, Presentation, Risk Factors, and Treatment. J Refract Surg. 2016; 32(8):534-41. DOI: 10.3928/1081597X-20160513-01. View

Buzzonetti L, Bohringer D, Liskova P, Lang S, Valente P . Keratoconus in Children: A Literature Review. Cornea. 2020; 39(12):1592-1598. DOI: 10.1097/ICO.0000000000002420. View

Masiwa L, Moodley V . A review of corneal imaging methods for the early diagnosis of pre-clinical Keratoconus. J Optom. 2020; 13(4):269-275. PMC: 7520528. DOI: 10.1016/j.optom.2019.11.001. View

10.

Gomes J, Tan D, Rapuano C, Belin M, Ambrosio Jr R, Guell J . Global consensus on keratoconus and ectatic diseases. Cornea. 2015; 34(4):359-69. DOI: 10.1097/ICO.0000000000000408. View

11.

Fournie P, Touboul D, Arne J, Colin J, Malecaze F . [Keratoconus]. J Fr Ophtalmol. 2013; 36(7):618-26. DOI: 10.1016/j.jfo.2013.05.004. View

12.

Weed K, MacEwen C, Giles T, Low J, McGhee C . The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing. Eye (Lond). 2007; 22(4):534-41. DOI: 10.1038/sj.eye.6702692. View

13.

Wagner H, Barr J, Zadnik K . Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007; 30(4):223-32. PMC: 3966142. DOI: 10.1016/j.clae.2007.03.001. View

14.

Zadnik K, Barr J, Gordon M, Edrington T . Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Cornea. 1996; 15(2):139-46. DOI: 10.1097/00003226-199603000-00006. View

15.

Fuller D, Wang Y . Safety and Efficacy of Scleral Lenses for Keratoconus. Optom Vis Sci. 2020; 97(9):741-748. PMC: 7547898. DOI: 10.1097/OPX.0000000000001578. View

16.

Gordon-Shaag A, Millodot M, Shneor E, Liu Y . The genetic and environmental factors for keratoconus. Biomed Res Int. 2015; 2015:795738. PMC: 4449900. DOI: 10.1155/2015/795738. View

17.

Mandathara P, Stapleton F, Willcox M . Outcome of Keratoconus Management: Review of the Past 20 Years' Contemporary Treatment Modalities. Eye Contact Lens. 2016; 43(3):141-154. DOI: 10.1097/ICL.0000000000000270. View

18.

Rocha-de-Lossada C, Prieto-Godoy M, Sanchez-Gonzalez J, Romano V, Borroni D, Rachwani-Anil R . Tomographic and aberrometric assessment of first-time diagnosed paediatric keratoconus based on age ranges: a multicentre study. Acta Ophthalmol. 2020; 99(6):e929-e936. DOI: 10.1111/aos.14715. View

19.

Blackburn B, Jenkins M, Rollins A, Dupps W . A Review of Structural and Biomechanical Changes in the Cornea in Aging, Disease, and Photochemical Crosslinking. Front Bioeng Biotechnol. 2019; 7:66. PMC: 6459081. DOI: 10.3389/fbioe.2019.00066. View

20.

Owens H, Gamble G . A profile of keratoconus in New Zealand. Cornea. 2003; 22(2):122-5. DOI: 10.1097/00003226-200303000-00008. View